-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $76

Benzinga·08/03/2026 15:32:55
Listen to the news
JP Morgan analyst Jessica Fye maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and raises the price target from $72 to $76.